The Newcastle Clinical Ageing Research Unit (CARU): a new facility for integrative and translational research on early assessment and treatment for older people. (360G-Wellcome-079394_Z_06_Z)
We will establish an innovative Clinical Ageing Research Unit (CARU) as part of the Newcastle Campus for Ageing and Health (CAH), which will focus on developing early assessment and intervention strategies targeted at age-associated degenerative conditions. Research on ageing and age-associated disease is a Department of Health priority. Newcastle is one of the world's leading centres for ageing research with our researchers attracting over £38m in awards over the last 8 years and more than £12.5m in the last year. CARU will be intimately linked with cutting-edge research on underpinning mechanisms of ageing, including physical and functional links with the newly constructed Magnetic Resonance Centre that comprises a world class MR physics team and is being directed by a clinician with wide experience of MR research. This will optimise focus on clinical research whilst harnessing cutting edge development of MR techniques. CARU will provide exceptional opportunities for translational studies. Demographic trends mean that age-related health problems command increasing clinical attention. For the majority of these health problems, age itself is the single biggest risk factor. It is therefore of key importance to understand why the aged cell or organ becomes more vulnerable to pathology and what can be done to intervene at early stages before the less tractable end-stage pathology has developed. CARU is needed to provide the necessary specialist clinical research infrastructure for the expanding major research hub of the Institute for Ageing and Health (IAH) at Newcastle General Hospital, including extensive research on dementia and brain ageing. The CAH already includes the Henry Wellcome Laboratory for Biogerontology Research, IAH Research Laboratories (with Newcastle Brain Tissue Resource and aged animal units), and the MR Centre. CARU will support research in three of the UKCRN research networks (dementia and neurodegenerative diseases, diabetes and stroke) and have close links with the Directors of the Stroke and DeNDRoN Research Network National Coordinating Centres (Ford, McKeith).
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 2666358 |
Applicant Surname | Ford |
Approval Committee | Clinical Research Initiative Scientific Advisory Committee |
Award Date | 2006-05-11T00:00:00+00:00 |
Financial Year | 2005/06 |
Grant Programme: Title | Building/Refurbishment Grant |
Internal ID | 079394/Z/06/Z |
Lead Applicant | Prof Gary Ford |
Partnership Name | Clinical Research Infrastructure Initiative |
Partnership Value | 2666358 |
Planned Dates: End Date | 2013-10-31T00:00:00+00:00 |
Planned Dates: Start Date | 2008-11-01T00:00:00+00:00 |
Recipient Org: Country | United Kingdom |
Region | North East |